LibraryBy pinki shah / May 14, 2022 Speciality — Amyotrophic Lateral Sclerosis (ALS) Biomarkers Biosimilars Bladder Blood Bone Brain Breast Cancer Central Nervous System (CNS) Clinical Trials Colon Colorectal Diversity, Equity & Inclusion Featured Content Gastrointestinal Genitourinary Genomic Geriatric Gynecology Head and Neck Hematologic Hematologic Maglinencies Hematology Immunotherapy Interventional Radiology Kidney Leukemia Liquid Biopsy Liver Lung Lymphoma Malignencies Melanoma Myelodysplastic Syndrome Myeloma Neuroendocrine Novel Oral & Maxillofacial Surgery Ovarian Pancreas Pancreatic Pharmacological Prostate Radiation Radiology Renal Sarcoma Skin Solid Tumor Supportive & Palliative Care Survivorship Telemedicine Thoracic Thrombosis Thymic Thyroid Urothelial Author / Speaker Title of Presentation Type of Media — Video Document Audio Event 2024 Event — 2024 California Cancer Consortium Conference (CCC) 2024 MLS Cleveland 2024 MLS Nashville 2024 MLS New Orleans 2024 MLS Seattle 2024 New Orleans Summer Cancer Meeting (NOSCM) 2024 PRIMO 2024 SPS Puerto Rico 2024 SPS Seattle 2024 SPECTRUM 2024 Sylvester APP Oncology Symposium 2024 WCS Clear Displaying 276 - 300 of 2,711 « 1 … 10 11 12 13 14 … 109 » Bench Lab Advances for Breast Cancer By: Mark Pegram, MD View Video PI3K and CDK4/6 Strategies: Efficacy Data and Management of Toxicity By: Mark Pegram, MD View Video New Developments in HER2+ Breast By: Mark Pegram, MD View PDF Immunotherapy for Breast Cancer: Updates and New Directions By: Mark Pegram, MD View PDF Immunotherapy for Breast Cancer: Updates and New Directions By: Mark Pegram, MD View Video Early Stage TNBC: Reviewing Different Strategies and Management By: Mark Pegram, MD View PDF Sequencing Therapy in Early Stage TNBC: Reducing and Increasing the Intensity of Therapy By: Mark Pegram, MD View Video Sequencing Therapy in Early Stage TNBC: Reducing and Increasing the Intensity of Therapy By: Mark Pegram, MD View PDF New Developments in HER2+ Breast By: Mark Pegram, MD View Video Early Stage TNBC: Reviewing Different Strategies and Management By: Mark Pegram, MD View Video Drug Development and New Targeted Agents for Breast Cancer: What Does the Future Hold? By: Mark Pegram, MD View PDF Drug Development and New Targeted Agents for Breast Cancer: What Does the Future Hold? By: Mark Pegram, MD View Video Triple Negative Breast Cancer: Optimal Strategies By: Mark Pegram, MD View PDF Controversies in Breast Cancer: Use of ctDNA to Tailor Systemic Adjuvant / Post-neoadjuvant Therapies By: Mark Pegram, MD & Joyce O’Shaughnessy, MD View PDF Breast Cancer Update in HER2 Breast Cancers By: Maryam Lustberg, MD, PhD View PDF Breast Cancer Update in HER2 Breast Cancers By: Maryam Lustberg, MD, PhD View Video Triple-negative and Hereditary Breast Cancer By: Melinda Telli, M.D. View PDF Triple-negative and Hereditary Breast Cancer By: Melinda Telli, M.D. View Video Recent Advances in Breast Cancer By: Melinda Telli, MD View PDF Recent Advances in Breast Cancer By: Melinda Telli, MD View Video Recent Advances in Breast Cancer By: Melissa Yacur, MD View PDF Anti-HER2 Therapies in Breast Cancer: Adjuvant and Neoadjuvant By: Michel Velez, MD View PDF Anti-HER2 Therapies in Breast Cancer: Adjuvant and Neodjuvant By: Michel Velez, MD View Video Triple Negative Breast Cancer/BRCA Mutated Breast Cancer: What's New? By: Mili Arora - MD View Video Advances in Oncology 2019: Breast Cancer Update By: Mili Arora - MD View Video
